Siemens Venture Capital

	BioImagene www.bioimagene.com BioImagene is a leading provider of total digital pathology solutions for applications including clinical diagnostics and drug discovery. BioImagene products are FDA -cleared for specific clinical applications, and are intended for research use for other applications.

	Chemclin Biotech Co., Ltd. http://www.chemclin.com Beijing Chemclin Biotech Co., Ltd. (Chemclin) was established in 1999, and has emerged as one of China's leading diagnostics companies with its own development, manufacturing and distribution headquartered in Beijing. Chemclin develops radioimmunoassay (RIA) kits, ELISA and chemiluminescent (CLIA) kits. The company has a well-established marketing and sales network across China with presence in 30 provinces, more than 2000 local districts and 30,000 towns.

	Cylex, Inc.® http://www.cylex.net Cylex is a life science company and a leader in the development and manufacture of unique products that use the immune system for predicting and managing human health. It is the first and only company to offer a patent- protected, FDA-cleared cellular assay of immune system function, ImmuKnow(tm), which measures the vitality of a patient's immune system from a single drop of blood. The company's products enable physicians to better manage and personalize the treatment of life-threatening diseases, such as HIV, HCV, cancer, diabetes, autoimmune and other disorders, as well as serious conditions associated with organ transplantation. ImmuKnow(tm) is currently being incorporated into patient protocols at leading U.S. hospitals and clinics. It is the only standardized cellular assay, easily performed in the lab, with quick and accurate results. By optimizing therapy, ImmuKnow(tm), helps the physician lower the cost of treatment and improve treatment outcome, reduce the side effects of drugs, and enhance the patient's prospects for long-term quality of life.

	LifeMasters® http://www.lifemasters.com (through SVC Corporate Fund) LifeMasters® Supported SelfCareSM, Inc. is a disease management services company, dedicated to providing quality healthcare and improved health outcomes for individuals with ongoing medical conditions and reducing medical expenses for payors. LifeMasters technology utilizes Web-based and interactive voice response delivery systems.

	MDdatacor, inc. http://www.mddatacor.com MDdatacor accesses and utilizes the richest source of relevant clinical information - patient medical records. The Company has developed proprietary and patent-pending technology that converts unstructured and structured text files, such as physician dictation, into a structured and searchable database. Pharmaceutical and medical device companies receive only patient de-identified reports; network member physician practices receive actionable patient identifiable reports. For the physicians, MDdatacor provides decision-support tools that enhance the practice's ability to conduct clinical research and monitor chronically ill patient populations, such as heart failure patients and high risk diabetics, over time to assist the treating physician and nurses in better managing disease and improving outcomes. For industry, the Company enables clinical trial sponsors to identify optimal investigator sites and subsequently accelerate the trial screening and enrollment process, reducing the time and cost of new product development.

	RadPharm http://www.radpharm.com RadPharm integrates expertise in medical imaging and drug development to enable the more rapid development of breakthrough treatments for cancer and other diseases. RadPharm provides the broadest range of image review and medical services for oncology drug development including central radiology review, radiation therapy QA services, oncology clinical reviews, medical photography reviews, and regulatory submission services.

	U-Systems, Inc. http://www.u-sys.com U-Systems, Inc. ("U-Systems"), founded in Silicon Valley in 1997, designs, develops, manufactures and markets innovative ultrasound systems to assist the radiologist in the diagnosis of breast cancer. The company has developed a leadership position in advanced ultrasound breast imaging systems and has incorporated proprietary hardware and software technology in the Full Field Breast Ultrasound System ("FFBU"). The FFBU automatically images the whole-breast and immediately presents the results to the physician in a standardized format making possible high volume.

	ZONARE Medical Systems, Inc. http://www.zonare.com (through SVC Corporate Fund) ZONARE Medical Systems, Inc. designs, develops, and manufactures high performance ultrasound solutions, which combine revolutionary technology with an innovative physical design. Zone Sonography technology, ZONARE's unique patented approach to ultrasound imaging, is focused on bringing premium performance to all clinical settings, leading to enhanced diagnostic capabilities, more cost effective operation and increased value to providers.

	up

	© Siemens Venture Capital GmbH 2003 - Corporate Information / Privacy Policy / Terms of Use
	June 18, 2007